10,541 research outputs found

    ์ˆ˜์šฉ์ฒด์˜ ์ž‘์šฉ์„ ์—ฐ๊ตฌํ•˜๊ธฐ ์œ„ํ•œ ์ƒ์ฒด๋ถ„์ž-ํƒ„์†Œ๋‚˜๋…ธํŠœ๋ธŒ ์œตํ•ฉ ๊ตฌ์กฐ ๋ฐ ๋ฐ”์ด์˜ค์ „์ž ์„ผ์„œ๋กœ์˜ ์‘์šฉ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ(๋ฐ•์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต๋Œ€ํ•™์› : ์ž์—ฐ๊ณผํ•™๋Œ€ํ•™ ๋ฌผ๋ฆฌยท์ฒœ๋ฌธํ•™๋ถ€(๋ฌผ๋ฆฌํ•™์ „๊ณต), 2022.2. ํ™์Šนํ›ˆ.Living organisms can perceive various external materials such as pathogens and tastants through sensory receptors. Various biosensors using these receptors have been developed for the monitoring of receptor activity and the detection of various molecules. Conventional methods using receptors include receptor-expressed cell-based devices or membrane receptor-based sensors. Recently, new types of nanostructures such as nanovesicles and nanodiscs have been introduced. However, these novel constructs have limitations such as low receptor expression yield and complicated production process. In this dissertation, the development and application of biosensors using new types of bioreceptors will be discussed. First, it will be discussed about the bioelectronic tongue devices using a ligand-binding domain of the human sweet taste receptor to monitor the activities of the receptor. In this work, only the VFT domain of the human sweet taste receptor was expressed. The VFT domain was immobilized on the floating electrodes of carbon nanotube field-effect transistors. We demonstrated the monitoring of the response of the receptor to the sweet taste substance using the device in real-time. In addition, by using this sensor, it was possible to analyze the enhancement and inhibition effect of sweet taste by various substances. Furthermore, it could be used to detect saccharides in real beverage samples. The sensor has the advantage of reusability and long-term storability. Our VFT domain-based bioelectronic tongue can be a powerful tool for the detection of sweet taste substances in the food and healthcare industry. Next, the monitoring of immune cell responses and their applications using antibody-inoculated immune cell-derived nanovesicles will be discussed. Nanovesicles were extracted from RBL-2H3 cells, and they were inoculated with IgE antibodies for the binding of target antigens. The nanovesicles were combined with carbon nanotubes field-effect transistors to fabricate an allergen biosensor. This biosensor can detect antigens in real-time, and it also enables the detection of allergens in real food. In addition, drug effects on the nanovesicle were evaluated. Importantly, we can easily obtain the antibody-inoculated nanovesicles for target antigens by inoculating antibodies. Therefore, our system can be an adaptive and universal platform for the detection and monitoring of various antigens.์‚ด์•„์žˆ๋Š” ์œ ๊ธฐ์ฒด๋Š” ๊ฐ๊ฐ ์ˆ˜์šฉ์ฒด๋ฅผ ์‚ฌ์šฉํ•˜๋Š” ๊ฐ๊ฐ ์‹œ์Šคํ…œ์„ ํ†ตํ•ด ๋ณ‘์›์ฒด ๋ฐ ๋ฏธ๊ฐ ๋ฌผ์งˆ๊ณผ ๊ฐ™์€ ๋‹ค์–‘ํ•œ ์™ธ๋ถ€ ๋ณ€ํ™”๋ฅผ ๊ฐ์ง€ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์ˆ˜์šฉ์ฒด๋ฅผ ํ™œ์šฉํ•œ ๋‹ค์–‘ํ•œ ๋ฐ”์ด์˜ค์„ผ์„œ๋“ค์ด ํ™œ์šฉ๋˜์–ด์˜ค๊ณ  ์žˆ๋‹ค. ๊ธฐ์กด์˜ ์ˆ˜์šฉ์ฒด ํ™œ์šฉ ๋ฐฉ์‹์œผ๋กœ๋Š” ์ˆ˜์šฉ์ฒด๊ฐ€ ๋ฐœํ˜„๋œ ์„ธํฌ๋ฅผ ํ™œ์šฉํ•˜๊ฑฐ๋‚˜, ๋ง‰๋‹จ๋ฐฑ์งˆ ์ž์ฒด๋ฅผ ์ด์šฉํ•˜๋Š” ๋ฐฉ๋ฒ•๋“ค์ด ์ผ๋ฐ˜์ ์ด๋‹ค. ์ตœ๊ทผ์—๋Š” ์ˆ˜์šฉ์ฒด๊ฐ€ ๋ฐœํ˜„๋œ ๋‚˜๋…ธ๋ฒ ์ง€ํด์ด๋‚˜ ๋‚˜๋…ธ๋””์Šคํฌ ๊ฐ™์€ ์ƒˆ๋กœ์šด ์ข…๋ฅ˜์˜ ๋‚˜๋…ธ๊ตฌ์กฐ์ฒด๋“ค์ด ๊ฐœ๋ฐœ๋˜์—ˆ๋‹ค. ํ•˜์ง€๋งŒ ์ด๋Ÿฌํ•œ ์ƒˆ๋กœ์šด ๊ตฌ์กฐ์ฒด๋“ค๋„ ๋‚ฎ์€ ์ˆ˜์šฉ์ฒด์˜ ๋ฐœํ˜„์œจ, ๋ณต์žกํ•œ ์ œ์กฐ ๋ฐฉ๋ฒ• ๋“ฑ์˜ ํ•œ๊ณ„์ ์ด ์žˆ๋‹ค. ์ด ํ•™์œ„๋…ผ๋ฌธ์—์„œ๋Š”, ์ด๋Ÿฌํ•œ ์ˆ˜์šฉ์ฒด ๊ธฐ๋ฐ˜ ๋‚˜๋…ธ๊ตฌ์กฐ์ฒด๋“ค์˜ ๋‹จ์ ์„ ๋ณด์™„ํ•˜๊ธฐ ์œ„ํ•œ ์ƒˆ๋กœ์šด ๊ตฌ์กฐ์˜ ์ˆ˜์šฉ์ฒด ๊ธฐ๋ฐ˜ ๋ฐ”์ด์˜ค๋ฆฌ์…‰ํ„ฐ๋“ค์„ ํ™œ์šฉํ•œ ๋ฐ”์ด์˜ค์„ผ์„œ ๊ฐœ๋ฐœ๊ณผ ๊ทธ ํ™œ์šฉ์— ๋Œ€ํ•ด ๋…ผ์˜ํ•œ๋‹ค. ๋จผ์ €, ์ธ๊ฐ„์˜ ๋‹จ๋ง› ์ˆ˜์šฉ์ฒด์˜ ์ž‘์šฉ์„ ๋ชจ๋‹ˆํ„ฐ๋งํ•˜๊ธฐ ์œ„ํ•œ ์ˆ˜์šฉ์ฒด์˜ ์ผ๋ถ€ ๋„๋ฉ”์ธ์„ ์ด์šฉํ•œ ๋ฐ”์ด์˜ค ์ „์žํ˜€ ์„ผ์„œ์— ๋Œ€ํ•ด ๋…ผ์˜ํ•  ๊ฒƒ์ด๋‹ค. ์ด๋ฅผ ์œ„ํ•˜์—ฌ, ์ธ๊ฐ„ ๋‹จ๋ง› ์ˆ˜์šฉ์ฒด์—์„œ VFT ๋„๋ฉ”์ธ๋งŒ์„ ๋ฐœํ˜„์‹œ์ผฐ๋‹ค. VFT ๋„๋ฉ”์ธ์„ ๋ถ€์œ  ์ „๊ทน์ด ์žˆ๋Š” ํƒ„์†Œ๋‚˜๋…ธํŠœ๋ธŒ ์ „๊ณ„ ํšจ๊ณผ ํŠธ๋žœ์ง€์Šคํ„ฐ์— ๊ฒฐํ•ฉ์‹œ์ผœ ๋‹จ๋ง› ๊ฐ์ง€ ์„ผ์„œ๋กœ ์ œ์ž‘ํ•˜์˜€๋‹ค. ์ด๋ฅผ ํ†ตํ•˜์—ฌ, ๋‹จ๋ง› ๋ฌผ์งˆ์— ๋Œ€ํ•œ ๋‹จ๋ง› ์ˆ˜์šฉ์ฒด์˜ ๋ฐ˜์‘์„ ์‹ค์‹œ๊ฐ„์œผ๋กœ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋˜ํ•œ, ์ด ์„ผ์„œ๋ฅผ ํ™œ์šฉํ•˜์—ฌ ๋‹ค์–‘ํ•œ ๋ฌผ์งˆ์— ์˜ํ•œ ๋‹จ๋ง›์˜ ํ–ฅ์ƒ ๋ฐ ์–ต์ œ ํšจ๊ณผ๋ฅผ ๋ถ„์„ํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๊ทธ๋ฆฌ๊ณ  ์‹ค์ œ ์Œ๋ฃŒ์— ์กด์žฌํ•˜๋Š” ๋‹น๋ฅ˜๋ฅผ ๊ฒ€์ถœํ•˜๋Š”๋ฐ๋„ ํ™œ์šฉํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ด ์„ผ์„œ๋Š” ์—ฌ๋Ÿฌ ๋ฒˆ ์žฌ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์˜ค๋žœ ๊ธฐ๊ฐ„ ๋ณด๊ด€ํ•  ์ˆ˜ ์žˆ๋Š” ์žฅ์ ์ด ์žˆ๋‹ค. ๋‹ค์Œ์œผ๋กœ, ๋ฉด์—ญ์„ธํฌ ์œ ๋ž˜ ๋‚˜๋…ธ๋ฒ ์ง€ํด์— ํ•ญ์ฒด๋ฅผ ์ ‘์ข…ํ•œ ์ƒˆ๋กœ์šด ์ข…๋ฅ˜์˜ ๋ฐ”์ด์˜ค๋ฆฌ์…‰ํ„ฐ๋ฅผ ํ™œ์šฉํ•œ ๋ฉด์—ญ ์„ธํฌ ๋ฐ˜์‘ ๋ชจ๋‹ˆํ„ฐ๋ง ๋ฐ ๊ทธ ํ™œ์šฉ์— ๋Œ€ํ•ด ๋…ผ์˜ํ•  ๊ฒƒ์ด๋‹ค. ๋ฉด์—ญ ์„ธํฌ์—์„œ ์ถ”์ถœํ•œ ๋‚˜๋…ธ๋ฒ ์ง€ํด์— ํ•ญ์ฒด๋ฅผ ์ ‘์ข…ํ•˜์—ฌ ๋‹ค์–‘ํ•œ ํ•ญ์›์— ๊ฒฐํ•ฉํ•  ์ˆ˜ ์žˆ๋Š” ๋ฐ”์ด์˜ค๋ฆฌ์…‰ํ„ฐ๋ฅผ ์ œ์ž‘ํ–ˆ๋‹ค. ์ด๋ฅผ ํƒ„์†Œ๋‚˜๋…ธํŠœ๋ธŒ์— ๊ฒฐํ•ฉํ•˜์—ฌ ํ•ญ์› ๊ฐ์ง€ ๋ฐ”์ด์˜ค ์„ผ์„œ๋กœ ์ œ์ž‘ํ•˜์˜€๋‹ค. ์ด ๋ฐ”์ด์˜ค์„ผ์„œ๋Š” ์‹ค์‹œ๊ฐ„์œผ๋กœ ํ•ญ์›์˜ ๊ฒ€์ถœ์ด ๊ฐ€๋Šฅํ•˜๋ฉฐ, ์‹ค์ œ ์Œ์‹์— ๋“ค์–ด์žˆ๋Š” ์•Œ๋Ÿฌ์   ๊ฒ€์ถœ๋„ ๊ฐ€๋Šฅํ•˜๋‹ค. ๋˜ํ•œ, ์•ฝ๋ฌผ์— ์˜ํ•œ ๋ฉด์—ญ ์„ธํฌ ๊ธฐ๋Šฅ ๋ณ€ํ™”๋ฅผ ํ‰๊ฐ€ํ•  ์ˆ˜ ์žˆ๋‹ค. ๋”์šฑ์ด, ํ•ญ์ฒด๊ฐ€ ์ ‘์ข…๋œ ๋‚˜๋…ธ๋ฒ ์ง€ํด์€ ํ•ญ์ฒด๋งŒ ๋ฐ”๊ฟ”์ฃผ๋ฉด ํƒ€๊ฒŸ ํ•ญ์›์— ๊ฒฐํ•ฉํ•˜๋Š” ๊ตฌ์กฐ๋ฅผ ์‰ฝ๊ฒŒ ์–ป์„ ์ˆ˜ ์žˆ์–ด ๋‹ค์–‘ํ•œ ํ•ญ์› ๊ฒ€์ถœ์— ๋ฒ”์šฉ์ ์œผ๋กœ ํ™œ์šฉํ•  ์ˆ˜ ์žˆ๋‹ค.Chapter 1. Introduction 1 1.1. Membrane Receptor Protein 2 1.2. Methods for the Monitoring of Receptor Activity 4 1.3. Carbon Nanotube Field-Effect Transistor 6 Chapter 2. Ultrasensitive Bioelectronic Tongue Based on Ligand Binding Domain of Sweet Taste Receptor for the Monitoring of Sweet Taste Receptor 8 2.1. Introduction 9 2.2. Fabrication of a Floating Electrode-Based Sweet Taste Sensor and Preparation of Samples 13 2.3. Characteristics of a Sweet Taste Sensor 16 2.4. Detection of Sweet Tastants by Using Sweet Taste Sensor 19 2.5. Evaluation of Sweet Substances in Real Beverages 24 2.6. Inhibition and Enhancement of Sweet Taste 27 2.7. Summary 30 Chapter 3. Nanovesicle-Based Biosensor for Monitoring of Immune Cell in Allergic Response 31 3.1. Introduction 32 3.2. Fabrication of an Immune Cell-Derived Sensor and Preparation of Samples 34 3.3. Characterization of Nanodisc-Immobilized CNT-FET 38 3.4. Monitoring of the Responses of Immune Cell-Derived Nanovesicles 40 3.5. Detection of Allergens in Real Food Samples 43 3.6. Summary 45 Conclusion 46 Bibliography 48 Abstract in Korean 56๋ฐ•

    Dual regulation of R-type CaV2.3 current by Gq-coupled receptors

    Get PDF
    Many high voltage-activated Ca2+ channels are modulated by Gq-coupled M1 muscarinic acetylcholine receptors. CaV2.3 currents are known to be increased by M1 receptor activation, and the increase in the CaV2.3 currents is mediated by phosphorylation of CaV2.3 channel via the activation of protein kinase C (PKC). Here, we report that M1 muscarinic receptors can also inhibit CaV2.3 currents when the channels are fully activated by PKC. In the whole-cell configuration of tsA201 cells, phorbol 12-myristate 13-acetate (PMA), a PKC activator, potentiated CaV2.3 currents by ~ 2-fold. We found that after the PMA-induced potentiation of CaV2.3 currents, application of the M1 receptor agonist oxotremorine-M (Oxo-M), decreased the currents by 52%. We examined if the hydrolysis of plasma membrane phosphoinositides (PIs) were involved in the muscarinic suppression of CaV2.3 currents. We used two methods to deplete PI(4,5)P2; voltage-sensing phosphatase (VSP), and rapamycin-induced translocatable pseudojanin (PJ) system. Activation of VSP suppressed CaV2.3 current by 38%. PJ system could directly dephosphorylate 4- and 5-phosphates from both PI(4)P and PI(4,5)P2 the plasma membrane. After the addition of rapamycin CaV2.3 currents were dramatically and irreversibly decreased by 66% compared to the initial level. Taken together, our results suggest that CaV2.3 currents are modulated by M1 receptor in a dual mode; potentiation by PKC activation and suppression by poly-PI depletion. Activation of M1 receptors can solely decrease CaV2.3 currents in the PKC-activated cells. PJ-induced inhibition of CaV2.3 currents demonstrates that poly-PIs are important in the maintenance of CaV2.3 channel activity. โ“’ 2015 DGIST1. Introduction 1 -- 2. Materials and methods 4 -- 2.1 Materials 4 -- 2.2 Cell culture 4 -- 2.3 Transfection 5 -- 2.4 Solution 5 -- 2.5 Chemicals 6 -- 2.6 Current recording 6 -- 2.7 Confocal imaging 6 -- 2.8 Data analysis 7 -- 3. Results 8 -- 3.1 CaV2.3 currents are suppressed as well as stimulated by M1 muscarinic receptor 8 -- 3.2 CaV2.3 currents are decreased by Dr-VSP activation 9 -- 3.3 CaV2.3 currents are decreased by chemically-induced phosphoinositide depletion 9 -- 4. Discussion 12 -- 5. Figure legends 15 -- 6. Figures 19 -- References 32 -- Abstract in Korean 36๋งŽ์€ ์ „์•• ๊ฐœํ ์นผ์Š˜ ์ฑ„๋„์€ Gq ๋‹จ๋ฐฑ์งˆ ์—ฐ๊ฒฐ ์ˆ˜์šฉ์ฒด (Gq-protein coupled receptor, GqPCR) ์ค‘ ํ•˜๋‚˜์ธ ๋ฌด์Šค์นด๋ฆฐ์„ฑ ์•„์„ธํ‹ธ์ฝœ๋ฆฐ ์ˆ˜์šฉ์ฒด์— ์˜ํ•ด์„œ ์กฐ์ ˆ๋œ๋‹ค. ์ „์•• ๊ฐœํ ์นผ์Š˜ ์ฑ„๋„ ์ค‘ CaV2.3 ์ฑ„๋„์˜ ์ „๋ฅ˜๋Š” M1 ๋ฌด์Šค์นด๋ฆฐ์„ฑ ์ˆ˜์šฉ์ฒด์— ์˜ํ•ด์„œ ์ฆ๊ฐ€ํ•˜๋ฉฐ ์ด ๋•Œ ์ „๋ฅ˜์˜ ์ฆ๊ฐ€๋Š” ๋‹จ๋ฐฑ์งˆ ์ธ์‚ฐํ™” ํšจ์†Œ C์— ์˜ํ•œ ์ฑ„๋„์˜ ์ธ์‚ฐํ™” ๋•Œ๋ฌธ์ด๋ผ๊ณ  ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ์‹ค์ œ๋กœ CaV2.3 ์ฑ„๋„์„ ๋ฐœํ˜„ํ•˜๋Š” tsA201 ์„ธํฌ์— phorbol 12-myristate 13-acetate (PMA) ๋ผ๋Š” ๋‹จ๋ฐฑ์งˆ ์ธ์‚ฐํ™” ํšจ์†Œ C์˜ ํ™œ์„ฑ์ œ๋ฅผ ์ฒ˜๋ฆฌํ•  ๊ฒฝ์šฐ CaV2.3 ์ฑ„๋„์˜ ์ „๋ฅ˜๊ฐ€ ๋‘ ๋ฐฐ ๊ฐ€๋Ÿ‰ ์ฆ๊ฐ€ํ•˜๋Š” ๊ฒƒ์„ ๋ณด์•˜๋‹ค. ํฅ๋ฏธ๋กœ์šด ์ ์€ PMA ๋ฅผ ์ฒ˜๋ฆฌํ•ด์„œ CaV2.3 ์ฑ„๋„์„ ์™„์ „ํžˆ ํ™œ์„ฑํ™” ์‹œํ‚จ ํ›„ M1 ์ˆ˜์šฉ์ฒด๋ฅผ ํ™œ์„ฑํ™” ์‹œํ‚ค๋ฉด CaV2.3 ์ฑ„๋„์˜ ์ „๋ฅ˜๊ฐ€ ์ค„์–ด๋“ ๋‹ค๋Š” ์ ์ด๋‹ค. ์šฐ๋ฆฌ๋Š” ์ „๋ฅ˜๋ฅผ ์–ต์ œ์‹œํ‚ค๋Š” ์š”์ธ์„ ์ฐพ๊ธฐ ์œ„ํ•ด์„œ M1 ์ˆ˜์šฉ์ฒด์— ์˜ํ•ด ์ผ์–ด๋‚˜๋Š” ์‹ ํ˜ธ์ „๋‹ฌ๊ณ„๋ฅผ ์‚ดํŽด๋ณด์•˜๋‹ค. M1 ์ˆ˜์šฉ์ฒด๊ฐ€ ํ™œ์„ฑํ™” ๋˜๋ฉด ์„ธํฌ๋ง‰์— ์žˆ๋Š” PI(4,5)P2 ๋ผ๋Š” ์ธ์ง€์งˆ์ด ๋ถ„ํ•ด๋œ๋‹ค. CaV2.3 ์ฑ„๋„๊ณผ ๊ฐ™์€ ๊ทธ๋ฃน์ธ CaV2.2 ์ฑ„๋„์ด PI(4,5)P2 ์–‘์ด ๊ฐ์†Œํ•˜๋ฉด ์ „๋ฅ˜๊ฐ€ ์ค„์–ด๋“ ๋‹ค๋Š” ๋ณด๊ณ ๊ฐ€ ์žˆ๊ธฐ ๋•Œ๋ฌธ์— PI(4,5)P2 ๊ฐ€ CaV2.3 ์ฑ„๋„์˜ ์–ต์ œ์—๋„ ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š”์ง€ ์•Œ์•„๋ณด๊ธฐ๋กœ ํ–ˆ๋‹ค. ์ฒซ ๋ฒˆ์งธ๋กœ ๋†’์€ ์ „์•• (+120 mV)์„ ๊ฐ€ํ•ด์คฌ์„ ๋•Œ ํ™œ์„ฑํ™”๋˜๋Š” ์ธ์‚ฐ ๊ฐ€์ˆ˜๋ถ„ํ•ด ํšจ์†Œ๋ฅผ ์ด์šฉํ–ˆ๋‹ค. ์šฐ๋ฆฌ๋Š” ์ด ๋ฐฉ๋ฒ•์„ ํ†ตํ•ด์„œ CaV2.3 ์ฑ„๋„์˜ ์ „๋ฅ˜๊ฐ€ 38% ๊ฐ€๋Ÿ‰ ์ค„์–ด๋“ ๋‹ค๋Š” ๊ฒƒ์„ ์•Œ์•„๋ƒˆ๋‹ค. ๋‘ ๋ฒˆ์งธ๋กœ ํŠน์ • ํ™”ํ•™๋ฌผ์งˆ์„ ์ฒจ๊ฐ€ํ•˜์˜€์„ ๋•Œ ๋‘ ๊ฐœ์˜ ๋ถ„์ž๊ฐ€ ์ดํ•ฉ์ฒดํ™” ๋˜๋Š” ํ˜„์ƒ์„ ์ด์šฉํ•˜๋Š” ๋ฐฉ๋ฒ•์„ ์‚ฌ์šฉํ–ˆ๋‹ค. ์ด ๋ฐฉ๋ฒ•์„ ์ด์šฉํ•ด์„œ ์ธ์‚ฐ ๊ฐ€์ˆ˜๋ถ„ํ•ด ํšจ์†Œ๋ฅผ ์„ธํฌ๋ง‰์œผ๋กœ ๊ฐ€์ ธ์˜ฌ ์ˆ˜ ์žˆ๊ณ  ์ธ์ง€์งˆ์„ ๋ถ„ํ•ด ํ•  ์ˆ˜ ์žˆ๋‹ค. ์šฐ๋ฆฌ๋Š” ๋ผํŒŒ๋งˆ์ด์‹ ์ด๋ผ๋Š” ํ™”ํ•™๋ฌผ์งˆ์„ ์ด์šฉํ•ด์„œ ์ธ์‚ฐ ๊ฐ€์ˆ˜๋ถ„ํ•ด ํšจ์†Œ๋ฅผ ์„ธํฌ๋ง‰์œผ๋กœ ์ด๋™์‹œํ‚จ ํ›„ PI(4,5)P2์˜ ์–‘์„ ๊ฐ์†Œ์‹œ์ผฐ๋‹ค. ๊ทธ ๊ฒฐ๊ณผ CaV2.3 ์ฑ„๋„์˜ ์ „๋ฅ˜๊ฐ€ 66% ์ •๋„ ์ค„์–ด๋“œ๋Š” ๊ฒƒ์„ ๋ฐœ๊ฒฌํ–ˆ๋‹ค. ์œ„์˜ ์‹คํ—˜๊ฒฐ๊ณผ๋“ค์€ CaV2.3 ์ฑ„๋„์˜ ์ „๋ฅ˜๊ฐ€ M1 ์ˆ˜์šฉ์ฒด์— ์˜ํ•ด์„œ ํ™œ์„ฑํ™” ๋  ์ˆ˜๋„ ์žˆ๊ณ  ์–ต์ œ๋  ์ˆ˜๋„ ์žˆ๋‹ค๋Š” ๊ฒƒ์„ ๋ณด์—ฌ์ค€๋‹ค. ํ™œ์„ฑํ™”๋˜๋Š” ๊ธฐ์ž‘์€ ๋‹จ๋ฐฑ์งˆ ์ธ์‚ฐํ™” ํšจ์†Œ C์—์˜ํ•œ CaV2.3 ์ฑ„๋„์˜ ์ธ์‚ฐํ™” ๋•Œ๋ฌธ์ด๊ณ  ์–ต์ œ๋˜๋Š” ๊ธฐ์ „์€ ์„ธํฌ๋ง‰์— ์žˆ๋Š” PI(4,5)P2 ์˜ ๊ฐ์†Œ์— ์˜ํ•œ ๊ฒƒ์ด๋‹ค. ์ด ์—ฐ๊ตฌ๋ฅผ ํ†ตํ•ด์„œ ์„ธํฌ๋ง‰์— ์žˆ๋Š” PI(4,5)P2๋Š” CaV2.3 ์ฑ„๋„์˜ ํ™œ์„ฑ์„ ์œ ์ง€ํ•˜๊ณ  ์กฐ์ ˆํ•˜๋Š”๋ฐ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•œ๋‹ค๋Š” ๊ฒƒ์„ ๋ฐํ˜€๋ƒˆ๋‹ค. โ“’ 2015 DGISTMasterdCollectio

    Mirage cosmology with an unstable probe D3-brane

    Full text link
    We consider the mirage cosmology by an unstable probe brane whose action is represented by BDI action with tachyon. We study how the presence of tachyon affects the evolution of the brane inflation. At the early stage of the brane inflation, the tachyon kinetic term can play an important role in curing the superluminal expansion in mirage cosmology.Comment: 11 pages, improved presentation with some clarifications, typos corrected, references adde

    Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models.

    Get PDF
    The goal of the present study was to determine whether insulin-like growth factor-1 receptor (IGF-1R) antibodies, conjugated with bright fluorophores, could enable visualization of pancreatic cancer in orthotopic nude mouse models. IGF-1R antibody (clone 24-31) was conjugated with 550 nm or 650 nm fluorophores. Western blotting confirmed the expression of IGF-1R in Panc-1, BxPC3, and MIAPaCa-2 human pancreatic cancer cell lines. Labeling with fluorophore-conjugated IGF-1R antibody demonstrated fluorescent foci on the membrane of the pancreatic cancer cells. Subcutaneous Panc-1, BxPC-3, and MIA PaCa-2 tumors became fluorescent after intravenous administration of fluorescent IGF-1R antibodies. Orthotopically-transplanted BxPC-3 tumors became fluorescent with the conjugated IGF-1R antibodies, and were easily visible with intravital imaging. Gross and microscopic ex vivo imaging of resected pancreatic tumor and normal pancreas confirmed that fluorescence indeed came from the membrane of cancer cells, and it was stronger from the tumor than the normal tissue. The present study demonstrates that fluorophore-conjugated IGF-1R antibodies can visualize pancreatic cancer and it can be used with various imaging devices such as endoscopy and laparoscopy for diagnosis and fluorescence-guided surgery

    Emotional Landscapes

    Full text link
    โ€œEmotional Landscapeโ€ delivers a sense of gravity, openness, and breathing space through oil paintings on linen of abstracted bodily forms. The imagery in the works generates an atmosphere where one can feel rooted and anxiety-free. The paintings invite a close read of the complexities of compounded affects

    Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models.

    Get PDF
    Fluorescent-antibody targeting of metastatic cancer has been demonstrated by our laboratory to enable tumor visualization and effective fluorescence-guided surgery. The goal of the present study was to determine whether insulin-like growth factor-1 receptor (IGF-1R) antibodies, conjugated with bright fluorophores, could enable visualization of metastatic colon cancer in orthotopic nude mouse models. IGF-1R antibody (clone 24-31) was conjugated with 550 nm, 650 nm or PEGylated 650 nm fluorophores. Subcutaneous, orthotopic, and liver metastasis models of colon cancer in nude mice were targeted with the fluorescent IGF-1R antibodies. Western blotting confirmed the expression of IGF-1R in HT-29 and HCT 116 human colon cancer cell lines, both expressing green fluorescent protein (GFP). Labeling with fluorophore-conjugated IGF-1R antibody demonstrated fluorescent foci on the membrane of colon cancer cells. Subcutaneously- and orthotopically-transplanted HT-29-GFP and HCT 116-GFP tumors brightly fluoresced at the longer wavelengths after intravenous administration of fluorescent IGF-1R antibodies. Orthotopically-transplanted HCT 116-GFP tumors were brightly labeled by fluorescent IGF-1R antibodies such that they could be imaged non-invasively at the longer wavelengths. In an experimental liver metastasis model, IGF-1R antibodies conjugated with PEGylated 650 nm fluorophores selectively highlighted the liver metastases, which could then be non-invasively imaged. The IGF-1R fluorescent-antibody labeled liver metastases were very bright compared to the normal liver and the fluorescent-antibody label co-located with green fluorescent protein (GFP) expression of the colon cancer cells. The present study thus demonstrates that fluorophore-conjugated IGF-1R antibodies selectively visualize metastatic colon cancer and have clinical potential for improved diagnosis and fluorescence-guided surgery
    • โ€ฆ
    corecore